Social networks shape the transmission dynamics of hepatitis C virus

PLoS ONE

Volumn 5, Issue 6, 2010, Pages 1-9

  Romano, Camila Malta ^a   de Carvalho Mello, Isabel M V Guedes ^a,b   Jamal, Leda F ^c   de Melo, Fernando Lucas ^a   Iamarino, Atila ^a   Motoki, Marco ^a   Pinho, João Renato Rebello ^a   Holmes, Edward C ^d,e   Zanotto, Paolo Marinho de Andrade ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c Secretary of Health of Sa o Paulo State   (Brazil)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5B;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAZIL; CONTROLLED STUDY; DRUG ABUSE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYLOGEOGRAPHY; PREVALENCE; PRISON; RISK FACTOR; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SOCIAL ASPECT; SOCIAL NETWORK; TATTOOING; TIME; UNINDEXED SEQUENCE; VIROGENESIS; VIRUS TRANSMISSION; CLASSIFICATION; DISEASE TRANSMISSION; SOCIAL SUPPORT;

HEPATITIS C; HUMANS; PHYLOGENY; SOCIAL SUPPORT;

EID: 77955285396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011170     Document Type: Article

References (46)

1. WHO (1999) Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. Journal of Viral Hepatitis 6: 35-47.
2. Trépo C, Pradat P (1999) Hepatitis C virus infection in Western Europe. Journal of Hepatology 31 Suppl 1: 80-83.
3. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, et al. (1995) Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J INFECT DIS 171: 1607-1610.
4. Matheï C, Van Dooren S, Lemey P, Van Damme P, Buntinx F, et al. (2008) The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium. Journal of Viral Hepatitis 15: 399-408.
5. Lopes CL, Teles SA, Espirito-Santo MP, Lampe E, Rodrigues FP, et al. (2009) Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saude Publica 43 Suppl 1: 43-50.
6. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL (1999) Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29: 908-914.
7. Reiche EMV, Bonametti AM, Morimoto HK, Morimoto AA, Wiechemann SL, et al. (2008) Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. INT J MOL MED 21: 387-395.
8. Simmonds P, Mellor J, Sakuldamrongpanich T, Nuchaprayoon C, Tanprasert S, et al. (1996) Evolutionary analysis of variants of hepatitis C virus found in South- East Asia: comparison with classifications based upon sequence similarity. J GEN VIROL 77 (Pt 12): 3013-3024.
9. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus-15 years on. J GEN VIROL 85: 3173-3188.
10. Dubois F, Desenclos JC, Mariotte N, Goudeau A (1997) Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 25: 1490-1496.
11. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, et al. (1995) Molecular epidemiology of hepatitis C virus infection among intravenous drug users. Journal of Hepatology 22: 691-695.
12. Pybus OG, Cochrane A, Holmes EC, Simmonds P (2005) The hepatitis C virus epidemic among injecting drug users. Infec Gene Evol 5: 131-139.
13. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, et al. (2009) The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6: e1000198.
14. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G (2006) A casecontrol study of risk factors for hepatitis C infection in patients with unexplained routes of infection. Journal of Viral Hepatitis 13: 775-782.
15. Brown KA (2005) Liver transplantation. Curr Opin Gastroenterol 21: 331-336.
16. Pardini MIdMC, Jamal LF, Durigon EL, Massad E, Perez JF, et al. (2008) Boosting virology in Brazil. PLoS Biol 6: e57-e57.
17. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 25: 4876-4882.
18. Zwickl DJ (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. Austin: The University of Texas at Austin.
19. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214-214.
20. Shapiro B, Rambaut A, Drummond AJ (2006) Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol 23: 7-9.
21. Lemey P, Rambaut A, Drummond AJ, Suchard MA (2009) Bayesian phylogeography finds its roots. PLoS Comput Biol 5: e1000520-e1000520.
22. Liljeros F, Edling CR, Amaral LA, Stanley HE, Aberg Y (2001) The web of human sexual contacts. Nature 411: 907-908.
23. Clauset A, Shalizi CR, Newman MEJ (2009) Power-Law Distributions in Empirical Data. Siam Review 51: 661-703.
24. Miller LH (1956) Table of Percentage Points of Kolmogorov Statistics. J Am Stat Assoc 51: 111-121.
25. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, et al. (2001) The epidemic behavior of the hepatitis C virus. Science 292: 2323-2325.
26. Rambaut A (2000) Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16: 395-399.
27. Grassly NC, Fraser C (2008) Mathematical models of infectious disease transmission. Nat Rev Microbiol 6: 477-487.
28. Chevaliez S, Pawlotsky JM (2007) Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13: 2461-2466.
29. Sherlock S (1993) European livers. Lancet 342: 1127-1128.
30. Mondini A, de Moraes Bronzoni RV, Nunes SH, Chiaravalloti Neto F, Massad E, et al. (2009) Spatio-temporal tracking and phylodynamics of an urban dengue 3 outbreak in Sao Paulo, Brazil. PLoS Negl Trop Dis 3: e448.
31. Martinez A, Talal AH (2008) Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 28: 757-760.
32. Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 18: 352-358.
33. Anderson RM, May RM (1992) A framework for the population biology of infectious diseases. Infectious diseases of humans. Oxford: Oxford University Press. pp 665-661.
34. Olsson GE, White N, Ahlm C, Elgh F, Verlemyr A-C, et al. (2002) Demographic factors associated with hantavirus infection in bank voles (Clethrionomys glareolus). Emerg Infect Dis 8: 924-929.
35. Friedman SR, Aral S (2001) Social networks, risk-potential networks, health, and disease. J Urban Health 78: 411-418.
36. Kiss IZ, Green DM, Kao RR (2005) Disease contact tracing in random and clustered networks. Proc Biol Sci 272: 1407-1414.
37. Alter MJ (2006) Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology 44: S6-9-S6-9.
38. Andrade AFB, Oliveira-Silva M, Silva SGC, Motta IJF, Bonvicino CR (2006) Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Memórias Do Instituto Oswaldo Cruz 101: 673-676.
39. de Oliveira T, Pybus OG, Rambaut A, Salemi M, Cassol S, et al. (2006) Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature 444: 836-837.
40. Nakano T, Lu L, He Y, Fu Y, Robertson BH, et al. (2006) Population genetic history of hepatitis C virus 1b infection in China. J Gen Virol 87: 73-82.
41. Nakano T, Lu L, Liu P, Pybus OG (2004) Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190: 1098-1108.
42. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A (2003) The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 20: 381-387.
43. McPherson M, Smith-Lovin L, Cook JM (2001) Birds of a Feather: Homophily in Social Networks. Annu Rev Sociol 27: 415-444.
44. Barabasi, Albert (1999) Emergence of scaling in random networks. Science 286: 509-512.
45. Newman MEJ (2003) The Structure and Function of Complex Networks. Siam Review 45: 167-256.
46. Shannon K, Kerr T, Marshall B, Li K, Zhang R, et al. (2010) Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drugusing youths in a canadian setting. Archives of Pediatrics and Adolescent Medicine 164: 61-65.